THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share

AI Boosts Biologic Breakthroughs
The biopharmaceutical landscape is rapidly expanding at a CAGR of 12.5%, with its market value set to rise from USD 333.09 billion in 2022 to USD 856.1 billion by 2030.

Targeted Disruption: The Rise of PARP Inhibitors
The market for PARP inhibitors, a cornerstone in targeted cancer treatment, is projected to more than triple from $3 billion in 2022 to an estimated $10.3 billion by 2031.

The Evolution of SMA Care
Despite the limited treatment options available, recent biological and technological advancements have sparked new hope, opening up novel opportunities for treatment and care.

Liquid Biopsies Redefine Cancer Care
The in vitro diagnostics (IVD) market, already valued at USD $102 billion in 2024, is on the brink of transformation, driven by the surge in liquid biopsy technologies.

RNA Therapeutics: A Focus on Antisense
Unlock the potential of antisense technology. Discover how RNA therapeutics can target previously ‘undruggable’ molecules for effective manipulation.

Epigenetics: Rewriting the Future of Aging
The field of epigenetics is progressing quickly, presenting a novel and exciting approach for precision medicine by altering gene expression with high precision and reversibility without changing the underlying DNA sequence.

Beyond Pills: The Tech Takeover in Migraine Management
Discover groundbreaking treatments and technological advancements for migraine relief. Find out how these new standards are changing patient expectations.

Beating the Odds: Next-Gen Therapies in Heart Disease
Discover the latest treatments for heart disease. From generic competition to innovative solutions, find out how the industry is evolving.

Swallowing a Biologic Drug?
Biological drugs — composed of proteins produced by living cells — have become some of the safest, most effective therapeutics in the pharmaceutical industry.

Breaking Down Drug Metabolism in Drug Development
Understand the process of drug metabolism and how our bodies respond to medication at a cellular level.

Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.